glp-1 drugs and hashimoto's GLP-1: what thyroid patients need to know before starting Patients Who Lose Weight After

While the clinical effects of tirzepatide have been very encouraging, important questions remain as to the mechanism of action

Berberine (BBR) exhibits significant anti-diabetic effects by enhancing insulin sensitivity, promoting glycolysis, and inhibiting gluconeogenesis

How retatrutide works: the first triple agonist targeting GIP, GLP-1, and glucagon receptors

Not for human or veterinary use

Not a fit for compounded GLP-1? You may still qualify for our Microdosing program, a lower dose option designed for patients outside the standard BMI range

Agents that agonize glucagon-like peptide 1 receptors, including those that co-agonize other anorexigenic hormone receptors, lead to substantial weight loss and benefits in people with varying obesity-related complications, with further trials underway